Latest News
Researchers have found a way to block a “master switch” in the eye and the brain that controls inflammation, introducing a possible target for combatting glaucoma and other neurodegenerative diseases.
In This Issue:
- Using Cells for Potential New Treatments
- President’s Corner
- Beyond Eye Pressure: New Avenue of Research
- And More!
Harnessing the power of artificial intelligence, researchers have identified nearly 200 previously unknown DNA regions linked to a risk of developing glaucoma, findings that could lead to new ways of preventing the disease.
Initial study results of an innovative glaucoma therapy involving eye implants have yielded positive results, and a Phase 2 clinical trial of this exciting potential treatment has begun.
BrightFocus-funded research offers the potential to restore vision loss due to glaucoma using cell replacement therapy.
January is National Glaucoma Awareness Month, and BrightFocus Foundation is offering a variety of free educational resources to help individuals with glaucoma and their loved ones navigate the disease.
A team of BrightFocus-funded scientists has proposed a new explanation and possible new target for treatment in glaucoma that’s unrelated to the common culprit of eye pressure.
In this issue:
- Glaucoma and Corneal Thickness
- President’s Corner
- Identifying New Risk Factors and Treatments for Glaucoma
- And more!
The newly expanded accessible audio program will connect patients with vision experts and provide the latest glaucoma research news.
Jason Meyer, PhD, is a BrightFocus Foundation success story and a pioneer in the effort to regenerate eye tissue that is damaged by glaucoma.
